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SocietyThe main conclusion of a recent study by Chow et al.1 is that
hyaluronidase-2 (Hyal2) is an intracellular protein that does
not appear on the surface of cultured cells, including human
chondrocytes. In contrast, previous studies from our labora-
tories have shown that Hyal2 is a glycosylphosphatidylinosi-
tol (GPI)-anchored cell-surface protein2e6. The role of Hyal2
in mammalian biology is still not known, but its localization
should provide clues. We ﬁnd the data provided in Chow
et al. inconclusive regarding the localization of Hyal2, and
provide data here showing that Hyal2 is indeed a GPI-
anchored cell-surface protein on human chondrocytes.
The initial characterization of Hyal2 by Lepperdinger
et al.7 indicated that it was a lysosomal hyaluronidase.
Hyal2 localization was analyzed by adding a green ﬂuores-
cent protein (GFP) tag to the carboxy terminus of Hyal2 and
by showing that GFP ﬂuorescence localized to lysosomes
after expression of the hybrid protein in a rat glioma cell
line. Hyal2 exhibited low but detectable hyaluronidase activ-
ity, and thus might play a role in hyaluronan degradation.
We became interested in Hyal2 when we found that it
served as the cell-entry receptor for jaagsiekte sheep retro-
virus (JSRV). Rodent cells are resistant to transduction by
retroviral vectors bearing the JSRV envelope protein
(JSRV vectors), but could be rendered susceptible by ex-
pression of human Hyal2 in the cells2. This result presented
a paradox because proteins that mediate virus entry are
found on the cell surface, and a lysosomal enzyme ap-
peared an unlikely retrovirus receptor! However, using
a protein topology prediction program, we found that
Hyal2 was likely to be a GPI-anchored protein. Such pro-
teins have endoplasmic reticulum (ER) signal sequences
at their amino termini, which direct the proteins to the ER
and are removed during protein translocation into the ER.
GPI-anchored proteins also have hydrophobic carboxy ter-
mini that are replaced with a GPI anchor that tethers the
proteins to the cell surface.
In an extensive series of experiments2, we showed that
an amino-terminal FLAG-tagged Hyal2 protein could also
function as a JSRV receptor and was indeed localized to
the cell surface, that an ER signal sequence was required
for cell-surface localization of Hyal2 and FLAG-tagged
Hyal2, that a known ER signal sequences from prepro-
trypsin could substitute for the putative ER signal
sequence of Hyal2, and that disruption of the putative
GPI-anchor signals in Hyal2 destroyed its receptor activ-
ity. Most importantly, we showed that treatment of
Hyal2-expressing cells with phosphatidylinositol-speciﬁc
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Received 21 July 2006.1phospholipase C (PI-PLC) released the majority of the
cell-associated Hyal2 into the culture medium and se-
verely reduced the ability of a JSRV vector to transduce
the cells. In the same experiment, transduction of the
cells with a retrovirus that uses a receptor for cell entry
that is not GPI-anchored was not affected by PI-PLC
treatment. In later studies we used ﬂow cytometric analy-
sis to show that the envelope protein of JSRV, which is
responsible for virus binding to and fusion with cells,
binds speciﬁcally to cells expressing Hyal23, we used sur-
face plasmon resonance analysis to show that puriﬁed
Hyal2 protein lacking the GPI anchor addition signals
binds speciﬁcally to JSRV envelope protein8, we have
mapped determinants in Hyal2 responsible for its activity
as a receptor for JSRV6, and we have shown that enzo-
otic nasal tumor virus (ENTV), a virus related to JSRV,
also binds to and uses Hyal2 for cell entry5,9. Thus the
evidence for cell-surface localization of Hyal2 is very
strong. The original localization of Hyal2 to lysosomes
is most likely incorrect due to the fact that the GFP tag
used to track Hyal2 was added to the carboxy terminus
of Hyal2, and was likely removed during GPI anchor ad-
dition and transported to lysosomes for degradation.
Against this backdrop, Chow et al.1 provide three lines of
evidence that Hyal2 is an intracellular protein that is not
found on the cell surface. First, they added a V5 epitope
tag to the carboxy end of Hyal2 and found that the V5-tag
localized to intracellular vesicles. This result is not surpris-
ing in light of the original experiments using a carboxy-tail
GFP tag. The tag is simply removed and transported to
lysosomes for degradation, and gives no information on
the actual localization of Hyal2.
Next Chow et al. attempted to add a Myc tag to the amino
terminus of Hyal2 to track Hyal2 localization. The descrip-
tion of this expression vector is incorrect in the Materials
and Methods (insertion of the Hyal2 cDNA into the pSec-
Tag2 expression vector, as described, would not add
a Myc tag to the amino terminus of Hyal2), but in correspon-
dence with the authors we learned that an ER signal se-
quence, followed by the Myc tag, was added upstream of
the Hyal2 ER signal sequence. Unfortunately, translocation
of this protein into the ER should result in removal of both
signal sequences and the intervening Myc tag. The authors
found that the Myc tag had an intracellular localization in
cells transfected with this construct, but because the Myc
tag should not be associated with the processed Hyal2 pro-
tein, this result provides no evidence for an intracellular lo-
calization for Hyal2. In our earlier experiments described
above, we successfully added a FLAG tag to the amino ter-
minus of Hyal2. In our expression construct we removed the
native Hyal2 signal sequence before adding the FLAG tag,
and added an ER signal sequence upstream of the tag2. In
this case the FLAG tag remained linked to Hyal2 and was
found at the cell surface.315
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peptide epitope from Hyal2, and found that these antibodies
reacted only with antigen in permeabilized cells. Again, this
evidence for Hyal2 localization inside the cell is not convinc-
ing because no data were presented to show that the anti-
bodies could recognize native Hyal2. Many antibodies that
recognize linear peptide epitopes cannot recognize these
epitopes in the properly-folded protein ( for examples, see
Ref.10). Thus it is entirely possible that these antibodies rec-
ognize only denatured/degraded Hyal2 protein found in
lysosomes.
So where is Hyal2 in chondrocytes? We have found
Hyal2 on the cell surface of many cell lines but had never
looked at chondrocytes. Perhaps Hyal2 is processed differ-
ently in these cells. To address this question we attempted
to transduce chondrocytes with a JSRV vector that encodes
human placental alkaline phosphatase (AP). As described
above, we have shown that Hyal2 is required for JSRV vec-
tor binding and entry into cells. We used the human chon-
drocyte cell line CH1.2, established from a human
chondrosarcoma, for this experiment. In culture, these cells
continue to synthesize cartilage-speciﬁc collagen types II,
IX, XI and aggrecan, known markers of the differentiated
chondrocyte phenotype. The titer of the JSRV vector on
CH1.2 cells was 2 103 APþ foci/ml of virus, a reasonably
high titer for this vector. The titer of a standard amphotropic
retrovirus vector encoding AP was 2 104 APþ foci/ml. Am-
photropic retroviruses use a different receptor for cell entry,
Pit211,12, and generally exhibit at least a 10-fold higher titer
on cells than the JSRV vector. Next we measured transduc-
tion following removal of GPI-anchored proteins using
PI-PLC from Bacillus cereus (Molecular Probes catalog
no. P-6466). CH1.2 cells were treated with or without PI-
PLC for 2 h, JSRV or amphotropic vectors were added
and allowed to bind/enter cells for an additional 4 h, then
the cells were washed and fresh medium was added. Three
days later the cells were stained for AP. Treatment of the
CH1.2 cells with PI-PLC led to a dramatic decrease in
JSRV vector transduction but had no effect on amphotropic
vector transduction (Table I). Note that these two vectors
are identical except for their envelope proteins. The ampho-
tropic envelope mediates virus fusion following binding to
Pit2, a multi-pass membrane protein that is not affected
by PI-PLC, while the JSRV envelope can only mediate virus
entry by binding to Hyal2. Thus we conclude that Hyal2 is
removed by PI-PLC treatment and is therefore linked to
the cell surface by a GPI anchor.
What about the other cell lines analyzed by Chow
et al.? Their Hyal2 antibody data provide anecdotal sup-
port for a cytoplasmic localization for Hyal2 in 293 human
embryonic kidney cells, but we have shown conclusively
that Hyal2 is a GPI-anchored cell-surface protein in 293
Table I
PI-PLC treatment of cells strongly inhibits JSRV vector transduction
but has no effect on amphotropic vector transduction. Results are







JSRV 0 3600 100
0.25 780 22
0.50 125 3
Amphotropic 0 21,000 100
0.25 24,000 114
0.50 21,000 100cells by both biochemical assays2 and by showing that
both JSRV and ENTV vectors can infect these cells9.
Similarly, Chow et al. provide antibody data suggesting
that Hyal2 is entirely intracellular in HeLa cells. These
cells are interesting in that they appear to express intact
Hyal2 mRNA but they are not infectable by JSRV or
ENTV vectors. However, expression of a normal human
Hyal2 cDNA in HeLa cells renders them susceptible to
JSRV vector infection, and vector infection is greatly re-
duced by treatment of the Hyal2-expressing cells with
PI-PLC, showing that normal human Hyal2 is transported
to the surface and is GPI-anchored in HeLa cells2. We
conclude that there is some defect in the endogenous
Hyal2 made in HeLa cells but have not further character-
ized this defect.
In summary, the evidence that Hyal2 is a GPI-anchored
cell-surface protein in chondrocytes and other cells is over-
whelming, and the conclusion of Chow et al. that Hyal2 is
an intracellular protein that is not found on the cell surface
is not adequately supported by any of the lines of evidence
they present. Like Hyal2, the hyaluronidase family member
Spam1 (PH-20) is also known to be a GPI-anchored pro-
tein13. Spam1 is involved in sperm adhesion to the oocyte
zona pellucida and has high hyaluronidase activity that is
important for sperm penetration of cumulus cells surround-
ing the oocyte. In contrast to Spam1, Hyal2 has relatively
low hyaluronidase activity and is widely expressed in mam-
mals. Important future questions involve the role of Hyal2 in
mammalian biology, which may include slow degradation of
hyaluronan at the cell surface, or perhaps sensing of extra-
cellular hyaluronan levels.
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